Is Blinatumomab an injection?

Blinatumomab (Blinatumomab) is a bispecific CD19-directed CD3 T cell engager. Bellintuzumab is produced in Chinese hamster ovary cells. Belintuzumab for injection is packaged in single-dose vials and is a sterile, preservative-free white to off-white lyophilized powder for intravenous injection. Each single-dose vial of blinatumomab contains 35 mcg of blinatumomab. Intravenous solution stabilizer is supplied in single-dose vials as a sterile, preservative-free, colorless to slightly yellow, clear solution. Bellintuzumab can be stored in the original carton in the dark at room temperature [3°C to 27°C (73°F to 81°F)] for up to 8 hours.